These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 37554115)
41. Long-term clinical and quality of life outcomes after stenting of femoropopliteal artery stenosis: 3-year results from the STROLL study. Bunte MC; Cohen DJ; Jaff MR; Gray WA; Magnuson EA; Li H; Feiring A; Cioppi M; Hibbard R; Gray B; Khatib Y; Jessup D; Patarca R; Du J; Stoll HP; Massaro J; Safley DM; Catheter Cardiovasc Interv; 2018 Jul; 92(1):106-114. PubMed ID: 29521013 [TBL] [Abstract][Full Text] [Related]
42. Propensity Score Analysis Comparing Clinical Outcomes of Drug-Eluting vs Bare Nitinol Stents in Femoropopliteal Lesions. Soga Y; Takahara M; Iida O; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Ando K J Endovasc Ther; 2016 Feb; 23(1):33-9. PubMed ID: 26763256 [TBL] [Abstract][Full Text] [Related]
43. Comparison of ultrasound-guided versus angiography-guided endovascular treatment for femoropopliteal artery occlusive disease. Tokuda T; Mori S; Oba Y; Koshida R; Kagase A; Matsuda H; Suzuki Y; Murata A; Ito T; Hirano K Catheter Cardiovasc Interv; 2021 Mar; 97(4):E518-E524. PubMed ID: 33314540 [TBL] [Abstract][Full Text] [Related]
44. Insights into endovascular treatment of long femoropopliteal lesions. Gouëffic Y J Cardiovasc Surg (Torino); 2022 Oct; 63(5):541-542. PubMed ID: 35758090 [No Abstract] [Full Text] [Related]
45. Predictability and usefulness of intravascular ultrasound-guided angioplasty in patients with femoropopliteal lesions. Jiang J; Xu W Int Angiol; 2022 Feb; 41(1):74-81. PubMed ID: 34825800 [TBL] [Abstract][Full Text] [Related]
46. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease. Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407 [TBL] [Abstract][Full Text] [Related]
48. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II). Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924 [TBL] [Abstract][Full Text] [Related]
49. Comparative Effectiveness of Endovascular Treatment Modalities for De Novo Femoropopliteal Lesions: A Network Meta-analysis of Randomized Controlled Trials. Zhou Y; Zhang Z; Lin S; Xiao J; Ai W; Wang J; Li Y; Li Q J Endovasc Ther; 2020 Feb; 27(1):42-59. PubMed ID: 31948375 [No Abstract] [Full Text] [Related]
50. Novel use of ultrasound guidance for recanalization of iliac, femoral, and popliteal arteries. Kawasaki D; Tsujino T; Fujii K; Masutani M; Ohyanagi M; Masuyama T Catheter Cardiovasc Interv; 2008 May; 71(6):727-33. PubMed ID: 18412065 [TBL] [Abstract][Full Text] [Related]
51. Intravascular ultrasound assessment of the effect of laser energy on the arterial wall during the treatment of femoro-popliteal lesions: a CliRpath excimer laser system to enlarge lumen openings (CELLO) registry study. Kuku KO; Garcia-Garcia HM; Koifman E; Kajita AH; Desale S; Azizi V; Melaku G; Bui A; Meirovich YF; Beyene S; Dheendsa A; Schneider B; Waksman R; Int J Cardiovasc Imaging; 2018 Mar; 34(3):345-352. PubMed ID: 28952037 [TBL] [Abstract][Full Text] [Related]
52. Vascular Pathology and Impact of Stent Eccentricity for Stent Restenosis in Femoropopliteal Endovascular Therapy. Mochidome T; Takahara M; Miura T; Soga Y; Fujihara M; Kawasaki D; Hirano K; Choi D; Iida O J Vasc Interv Radiol; 2022 Sep; 33(9):1089-1096. PubMed ID: 35671987 [TBL] [Abstract][Full Text] [Related]
53. A Novel Angiographic Risk Score for Femoropopliteal Interventions. Iida O; Takahara M; Soga Y; Fujihara M; Kawasaki D; Hirano K; Choi D; Mano T J Endovasc Ther; 2020 Dec; 27(6):967-973. PubMed ID: 32813589 [TBL] [Abstract][Full Text] [Related]
54. Self-expanding nitinol stents of high versus low chronic outward force in de novo femoropopliteal occlusive arterial lesions (BIOFLEX-COF trial): study protocol for a randomized controlled trial. Wressnegger A; Kaider A; Funovics MA Trials; 2017 Dec; 18(1):594. PubMed ID: 29237489 [TBL] [Abstract][Full Text] [Related]
55. Clinical outcomes of endovascular treatment of TASC-II C and D femoropopliteal lesions with the Viabahn endoprosthesis. Mohr PJ; Oyama JK; Luu JT; Stinis CT Cardiovasc Revasc Med; 2015 Dec; 16(8):465-8. PubMed ID: 26483319 [TBL] [Abstract][Full Text] [Related]
57. Long-term results of the heparin-bonded Viabahn stent graft in femoropopliteal TASC C and D lesions with a covered stent length of minimum 25 cm. Uhl C; Dadras A; Reichmann F; Betz T; Zorger N; Toepel I; Steinbauer M Vascular; 2019 Oct; 27(5):553-559. PubMed ID: 30917750 [No Abstract] [Full Text] [Related]
58. Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort. Brodmann M; Keirse K; Scheinert D; Spak L; Jaff MR; Schmahl R; Li P; Zeller T; JACC Cardiovasc Interv; 2017 Oct; 10(20):2113-2123. PubMed ID: 29050631 [TBL] [Abstract][Full Text] [Related]
59. Ultrasound-Guided Retrograde Infrapopliteal Artery Access for Recanalization of Complex Femoral-Popliteal Artery Occlusions. Zhang H; Niu L; Zhang F; Luo X; Feng Y; Zhang C Ann Vasc Surg; 2021 Oct; 76():357-362. PubMed ID: 33910048 [TBL] [Abstract][Full Text] [Related]
60. Comparison Between Interwoven Nitinol and Drug Eluting Stents for Endovascular Treatment of Femoropopliteal Artery Disease. Haine A; Schmid MJ; Schindewolf M; Lenz A; Bernhard SM; Drexel H; Baumgartner I; Dopheide JF Eur J Vasc Endovasc Surg; 2019 Dec; 58(6):865-873. PubMed ID: 31668949 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]